NRx Pharmaceuticals, Inc.NRXPNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank43
3Y CAGR-62.6%
5Y CAGR+1091.9%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-62.6%/yr
vs +180.0%/yr prior
5Y CAGR
+1091.9%/yr
Recent deceleration
Acceleration
-242.6pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
240500x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$1.44M-68.6%
2023$4.59M-77.1%
2022$20.05M-27.4%
2021$27.61M+1384.9%
2020$1.86M+30983233.3%
2019$6.00-99.9%
2018$11079.00-97.5%
2017$449374.00-